Caracterización clínica y metabólica de pacientes con diagnóstico de urolitiasis en una clínica de cuarto nivel en la ciudad de Barranquilla en el año 2019
Cargando...
Fecha
2020
Autores
Vicente Pérez, Rafael
Título de la revista
ISSN de la revista
Título del volumen
Editor
Ediciones Universidad Simón Bolívar
Facultad de Ciencias de la Salud
Facultad de Ciencias de la Salud
Resumen
Introducción:La urolitiasis es una enfermedad con alta frecuencia y nuestro
medio no es la excepción, en Colombia se han publicado estudios previos, sin
embargo, estos no comparan las características sociodemográficas y clínicas de
los pacientes con las comorbilidades y factores predisponentes de litiasis como lo
son hiperuricemia, hipertensión arterial, obesidad y enfermedad renal crónica
(ERC).
Objetivos:Caracterizar clínica y metabólicamentelos pacientes con diagnóstico de
urolitiasis en una clínica de cuarto nivel de la ciudad de Barranquilla en el año
2019.
Materiales y Métodos:Estudio observacional, descriptivo, transversal. Se realizó
un análisis determinando medidas de tendencia central, dispersión y frecuencias
asociado a un análisis bivariado.
Resultados:Se incluyeron 49 pacientes. La mediana de edad fue 58 años, el sexo
masculino en 53,1%. La mediana del índice de masa corporal fue de 26,4Kg/m2.
Se identificó hipertensión arterial en 69,4%, enfermedad renal crónica (ERC) en
36,7%, infección de vías urinarias recurrente en 24,5%. Hiperuricemia en 44,9%,
hipercalcemia en 16,3% e hiperfosfatemia en 12,2%.Los tipos de cristal fueron
oxalato en 20,4%, urato en 12,2%, mezcla de los previos en 4,1% y en igual
proporción fosfato. Hipercalciuria e hiperoxaluria en 38,8%, hiperuricosuria e
hipocalciuria en 18,4%, mientras hiperfosfaturia o hipofosfaturia en 4,1%.La
hiperuricemia se asoció a edad (p=0,028), ERC (p=0,026), medicamentos
antihipertensivos (p=0,022), la posición del cálculo en cáliz renal (p= 0,012),
hiperparatiroidismo (p= 0,007), depuración de creatinina (p= 0,046) e hipercalciuria
(p= 0,049).IMC ≥30 se asoció con ERC estadio 5 (p=0,025), diálisis (p=0,025) y
hiperoxaluria (p= 0,021).
Conclusiones:Se evidencio en pacientes con urolitiasis una frecuencia
significativa de ERC, hiperuricemia, obesidad e hipertensión arterial.
Background: Urolithiasis is a disease with high frequency and our environment is no exception. Previous studies have been published in Colombia; however, they do not evaluate Caribbean regionpopulation. Objectives: to characterize clinically and metabolically patients diagnosed with urolithiasis in the clinic of La Costa in Barranquilla in 2019. Materials and Methods: observational, descriptive, cross-sectional study. An analysis was carried out determining measures of central tendency, dispersion and frequencies associated with a bivariate analysis. Results: 49 patients were included. The median age was 58 years, the male sex in 53.1%. The median body mass index was 26.4 Kg/m2. Arterial hypertension was identified in 69.4%, chronic kidney disease (CKD) in 36.7%, recurrent urinary tract infection in 24.5%. Hyperuricemia in 44.9%, hypercalcemia in 16.3% and hyperphosphatemia in 12.2%. The crystal types were oxalate in 20.4%, urate in 12.2%, mixture of the previous ones in 4.1% and in the same proportion phosphate. Hypercalciuria and hyperoxaluria in 38.8%, hyperuricosuria and hypocalciuria in 18.4%, while hyperphosphaturia or hypophosphaturia in 4.1%. Hyperuricemia was associated with age (p=0.028), CKD (p=0.026), antihypertensive drugs (p=0.022), the position of the stone in renal calyx (p = 0.012), hyperparathyroidism (p=0.007), creatinine clearance (p = 0.046) and hypercalciuria (p = 0.049). BMI ≥30 was associated with stage 5 CKD (p = 0.025), dialysis (p = 0.025), and hyperoxaluria (p=0.021). Conclusions: A statistically significant relationship of urolithiasis and CKD, hyperuricemia, obesity and hypertension was evidenced. It is an analysis that allows a comparison to be made with other populations already described previously.
Background: Urolithiasis is a disease with high frequency and our environment is no exception. Previous studies have been published in Colombia; however, they do not evaluate Caribbean regionpopulation. Objectives: to characterize clinically and metabolically patients diagnosed with urolithiasis in the clinic of La Costa in Barranquilla in 2019. Materials and Methods: observational, descriptive, cross-sectional study. An analysis was carried out determining measures of central tendency, dispersion and frequencies associated with a bivariate analysis. Results: 49 patients were included. The median age was 58 years, the male sex in 53.1%. The median body mass index was 26.4 Kg/m2. Arterial hypertension was identified in 69.4%, chronic kidney disease (CKD) in 36.7%, recurrent urinary tract infection in 24.5%. Hyperuricemia in 44.9%, hypercalcemia in 16.3% and hyperphosphatemia in 12.2%. The crystal types were oxalate in 20.4%, urate in 12.2%, mixture of the previous ones in 4.1% and in the same proportion phosphate. Hypercalciuria and hyperoxaluria in 38.8%, hyperuricosuria and hypocalciuria in 18.4%, while hyperphosphaturia or hypophosphaturia in 4.1%. Hyperuricemia was associated with age (p=0.028), CKD (p=0.026), antihypertensive drugs (p=0.022), the position of the stone in renal calyx (p = 0.012), hyperparathyroidism (p=0.007), creatinine clearance (p = 0.046) and hypercalciuria (p = 0.049). BMI ≥30 was associated with stage 5 CKD (p = 0.025), dialysis (p = 0.025), and hyperoxaluria (p=0.021). Conclusions: A statistically significant relationship of urolithiasis and CKD, hyperuricemia, obesity and hypertension was evidenced. It is an analysis that allows a comparison to be made with other populations already described previously.
Descripción
Palabras clave
Urolitiasis, Estudio metabólico, Epidemiologia, Colombia, Urolithiasis, Metabolic study, Epidemiology, Colombia
